Kazuki Ichikawa

Papers

Total Citations

H-Index

About

Dr. Kazuki Ichikawa is a leading urologic oncologist whose research centers on optimizing surgical outcomes for renal cell carcinoma, with a particular focus on the nuances of partial nephrectomy. His most cited work critically examines the phenomenon of intraoperative tumor capsule injury (TCI) during robot-assisted (RAPN) and laparoscopic partial nephrectomy (LPN). By meticulously investigating the incidence and long-term oncological impact of TCI, Dr. Ichikawa has provided surgeons with crucial insights into preserving the tumor capsule's integrity, directly influencing surgical technique to reduce recurrence risks. His 2025 study, which has already garnered early citations, underscores his role in refining the safety profile of nephron-sparing surgery. Through this work, Dr. Ichikawa has helped establish a more precise understanding of intraoperative factors that affect patient prognosis, bridging the gap between surgical mechanics and oncological outcomes. His contributions are shaping best practices in minimally invasive renal surgery, making him a key voice in the ongoing effort to improve survival and quality of life for kidney cancer patients.